Search

Your search keyword '"Corinna Pade"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Corinna Pade" Remove constraint Author: "Corinna Pade"
37 results on '"Corinna Pade"'

Search Results

1. Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination

2. Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

3. Curbside particulate matter and susceptibility to SARS–CoV-2 infection

4. Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

5. Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response

6. The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19

7. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial

8. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19 [version 2; peer review: 1 approved, 2 approved with reservations]

9. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.

11. Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study

12. Persistent symptoms after COVID-19 during the first wave are not associated with differential immunity to SARS-CoV-2

13. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

14. Influence of vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity

15. Immune boosting by B.1.1.529

16. Correlation between post-vaccination titres of combined IgG, IgA, and IgM anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study (COVIDENCE UK)

17. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections

18. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19

19. Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease

21. Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease

22. The β-NGF/TrkA signalling pathway is associated with the production of anti- nucleoprotein IgG in convalescent COVID-19

23. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection

24. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study

25. Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling

26. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

27. Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave

28. Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors reply

29. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19

30. Interferon epsilon promotes HIV restriction at multiple steps of viral replication

31. Cryo-electron microscopy and single molecule fluorescent microscopy detect CD4 receptor induced HIV size expansion prior to cell entry

32. CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants

33. Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses

34. A whole genome screen for HIV restriction factors

35. Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection

36. P04-35. Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patients

37. Condensin Regulates rDNA Silencing by Modulating Nucleolar Sir2p

Catalog

Books, media, physical & digital resources